These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7047275)

  • 1. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

  • 2. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 3. C-peptide: a new method of assessing pancreatic beta-cell function.
    Cahill GF
    N Engl J Med; 1973 May; 288(22):1181-2. PubMed ID: 4573125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of insulin secretory capacity in diabetes mellitus.
    Horwitz DL; Rubenstein AH
    Hum Pathol; 1979 May; 10(3):257-66. PubMed ID: 381153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin secretory capacity in Singapore diabetic subjects.
    Thai AC; Yeo PP; Chan L; Wang KW; Lui KF; Cheah JS; Tan BY
    Ann Acad Med Singap; 1985 Apr; 14(2):191-3. PubMed ID: 3898977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical role of the determination of immunoreactive insulin and C-peptide in children with diabetes mellitus].
    Kravets EB
    Pediatriia; 1983 Mar; (3):42-4. PubMed ID: 6346250
    [No Abstract]   [Full Text] [Related]  

  • 10. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 12. C-peptide: an index of insulin secretion.
    Faber OK; Binder C
    Diabetes Metab Rev; 1986; 2(3-4):331-45. PubMed ID: 3527619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin reserve of insulin-dependent diabetics. Role of C-peptide in the hormonal balance in diabetes].
    Dauzat J; Moinade S; Gaillard G; Glanddier Y; Gachon AM
    Presse Med; 1983 Sep; 12(32):1983-7. PubMed ID: 6225101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationships between body weight, insulin secretion from B cell and metabolic control in type 2 (non-insulin-dependent) diabetics with fasting hyperglycemia.
    Pasquali R; Buratti P; Biso P; Mattioli L; Capelli M; Melchionda N; Labò G
    Panminerva Med; 1987; 29(3):181-8. PubMed ID: 3320883
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus.
    Frier BM; Faber OK; Binder C; Elliot HL
    Diabetologia; 1978 May; 14(5):301-4. PubMed ID: 348540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secretory potentialities of beta cells at early stages of diabetes mellitus].
    Ruiatkina LA; Dikker VE; Galenok VA
    Med Radiol (Mosk); 1986 Feb; 31(2):81-4. PubMed ID: 3512952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
    Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
    Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
    Starostina EG; Lobanova AM; Magomedova AK
    Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood serum C-peptide level after arginine stimulation in the early and later stage of insulin-dependent diabetes].
    Miedzińska-Szadkowska E; Lawecki J; Symonides-Lawecka A
    Pol Arch Med Wewn; 1980 Nov; 64(5):421-9. PubMed ID: 7012801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.